ClinicalTrials.gg
CompletedNCT02129049Updated Mar 9, 2016

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

An interventional study of educational intervention and telephone-based intervention in Breast Cancer, Cervical Cancer and Colon Cancer, sponsored by University of Washington. Completed at 11 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-03-09.

Sponsored by University of Washington · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This pilot clinical trial studies the feasibility of a telephone-based educational intervention in improving communication between patients with stage 0-III cancer and their children. An educational program delivered by telephone may help parents talk with their school-age child about their cancer.

Read the detailed description

PRIMARY OBJECTIVES:

I. Test the feasibility of the recruitment and study protocol.

II. Evaluate the short-term impact of the program on the diagnosed parents' and the parent's perceptions of their children's adjustment using a within group design (pre-posttest design).

III. To compare outcomes from the telephone-delivered program with outcomes obtained from the in-person program (between group design).

OUTLINE:

Participants complete the Enhancing Connections Telephone Program comprising 5, 1 hour educational telephone sessions over 3 months. During session 1, parents receive help defining the child's experience with the cancer as distinct from their own and ways to manage their own cancer-related emotions so that they do not emotionally flood the child. During session 2, parents receive assistance with developing skills to deeply listen and attend to the child's thoughts and feelings, complementing the parent's tendency to be a teacher, not a deep listener, of the child's thoughts, concerns, worries or understandings. During session 3, parents receive additional communication and parenting skills enabling them to initiate difficult cancer-related conversations and also interact with an upset child or one who is not forthcoming. During session 4, parents receive help focusing on and non-judgmentally interpreting the child's ways of coping with the cancer. It includes exercises that assist the parent to relinquish negative assumptions about the child's behavior related to the parent's cancer. Concurrently the session offers the ill parent ways to elicit their child's report of what the parent can do to assist the child cope with the child's cancer-related pressures. During session 5, parents focus on the gains they made in prior sessions and what they have accomplished, in their own words, in parenting their child about the cancer. The session also assists the ill parent to identify available resources that can be used after program completion to maintain the parent's newly acquired gains from the program.

02

Conditions studied

  • Breast Cancer
  • Cervical Cancer
  • Colon Cancer
  • Leukemia
  • Lymphoma
  • Malignant Neoplasm
  • Melanoma
  • Rectal Cancer
03

In context

Breast Neoplasms

12,815 studies on the registry are indexed under Breast Neoplasms; 2,920 are open to participants now.

This study's enrollment of 35 is below the median of 72 across 9,494 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Washington is the lead sponsor of 1,431 studies on the registry; 226 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Parents will be eligible if they have an initial diagnosis of non-metastatic cancer of any type (stage 0-3), including melanoma, colorectal, cervical, leukemia, lymphoma or breast cancer within the past 7 months
  • Read and write English among their languages of choice
  • Have ready access to a telephone
  • Have a child 5-12 years old living at home who has been told their parent's cancer diagnosis
  • The child is living at home and does not have learning challenges
  • No prior malignancy is allowed except for adequately treated basal (or squamous cell) skin cancer
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Supportive care (Enhancing Connections Telephone Program)

    See Detailed Description.

    Other: educational intervention · Behavioral: telephone-based intervention · Other: questionnaire administration

Interventions

  • Othereducational intervention

    Participate in the Enhancing Connections Telephone Program

    Also known as: intervention, educational

  • Behavioraltelephone-based intervention

    Participate in the Enhancing Connections Telephone Program

  • Otherquestionnaire administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Recruitment and retention, monitored by tracking detailed recruitment spreadsheets

    Each referral source and method of referral will be monitored, including documenting reason for refusal. Four methods of recruitment will be monitored in order to know which method yields the highest enrollment: self-referral, provider referral, passive letter opt-in, and passive letter opt-out.

    Time frame: Up to 3 months

  2. Dosage and fidelity, monitored for each intervention session using Performance Checklists

    Each audio-recorded intervention session will be reviewed against these checklists. Study participants' compliance with the in-session and at-home assignments will be monitored by the audio-recorded intervention sessions.

    Time frame: Up to 3 months

  3. Acceptability of the program, assessed from interview data obtained from the Exit interview and the Swanson Caring Professional Scale

    Time frame: Up to 3 months

  4. Rate of receipt of mailed materials both to participants and from participants

    Materials include signed consents, baseline data, and parent's educational materials.

    Time frame: Up to 3 months

  5. Duration of phone intervention sessions

    Time frame: Up to 3 months

  6. Rate of success in scheduling and completing intervention sessions by telephone

    Time frame: Up to 3 months

  7. Quality of data on baseline and post-intervention measures

    Time frame: Up to 3 months

  8. Short-term impact of the program, evaluated by comparing the change in pre- and post-test scores on the standardized questionnaires

    Analysis of covariance (ANCOVA) will be used to test for significant differences between pre- and post-test scores, assuming the data meet the statistical assumptions. Baseline scores will serve as the covariate, along with empirical variables that are known to co-vary with parent and child functioning, e.g., length of time of diagnosis, type of medical treatment, adjuvant therapy, among others). Two-tailed tests of significance will be calculated, allowing us to evaluate any potential negative effects of the intervention.

    Time frame: Baseline up to 3 months

  9. Impact of the telephone-delivered compared to the in-person delivered program

    Linear mixed modeling will be used. Random effects models are based on Maximum Likelihood Estimation in which an iterative method estimates a trajectory for each study participant based on all available data for that participant supplemented by data obtained from the total sample.

    Time frame: Up to 3 months

07

Study locations

11 sites
  • Bozeman Deaconess Hospital
    Bozeman, Montana 59715, United States
  • Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336, United States
  • Tri-Cities Cancer Center
    Kennewick, Washington 99336, United States
  • SCCA at EvergreenHealth
    Kirkland, Washington 98033, United States
  • Skagit Valley Hospital
    Mount Vernon, Washington 98274, United States
  • Olympic Medical Center
    Port Angeles, Washington 98362, United States
  • Group Health Cooperative
    Redmond, Washington 98052, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Seattle, Washington 98109, United States
  • Swedish Cancer Institute
    Seattle, Washington 98122-4307, United States
  • Multicare Health System
    Tacoma, Washington 98415, United States
  • Wenatchee Valley Medical Center
    Wenatchee, Washington 98801, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02129049
Responsible party
Sponsor
First posted
May 2, 2014
Start date
Apr 2014
Primary completion
Jul 2015
Last update
Mar 9, 2016

Study contacts

Frances Lewis
principal investigator · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion